Skip to main content
. 2014 Dec 16;100(3):1088–1096. doi: 10.1210/jc.2014-3586

Table 3.

Risk of Hip Fracture, Dementia, and Total Mortality for a One Unit Higher TSH, FT4, or Total T3

Model No. of Events/No. at Risk TSH, mU/L
Free T4, pmol/L
Total T3, nmol/L
HR 95% CI P Value HR 95% CI P Value HR 95% CI P Value
Hip fracture 340/2803
    Model 1 0.93 0.83–1.04 .20 0.99 0.94–1.05 .79 1.07 0.74–1.55 .73
    Model 2 0.94 0.84–1.05 .26 0.98 0.94–1.04 .56 1.03 0.71–1.51 .86
Dementia 229/1824
    Model 1 0.87 0.76–1.00 .05 1.04 0.97–1.10 .26 1.01 0.63–1.59 .98
    Model 2 0.88 0.76–1.01 .07 1.02 0.96–1.09 .52 1.06 0.66–1.68 .81
Total Mortality 2161/2843
    Model 1 0.95 0.91–0.99 .03 1.03 1.01–1.05 .007 1.12 0.97–1.30 .12
    Model 2 0.96 0.91–1.00 .05 1.01 0.99–1.03 .17 1.12 0.96–1.30 .15

Model 1 for hip fracture and total mortality are adjusted for age, sex, race, and initiation of thyroid meds (time varying). Model 1 for dementia also includes an age2 term.

Model 2 for hip fracture additionally adjusted for oral steroid use, kilocalories of exercise (ln), current smoking, alcohol use, and weight.

Model 2 for dementia additionally adjusted for body mass index (BMI), hypertension, diabetes, current smoking, any alcohol use, total cholesterol, stroke history, claudication, and apoe4 genotype.

Model 2 for mortality additionally adjusted for BMI, hypertension, diabetes, current smoking, coronary heart disease, heart failure, stroke, claudication, depression score, creatinine, and kcal of activity.